1 – 100 of 135
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
BioMEL : a translational research biobank of melanocytic lesions and melanoma
(
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
- 2022
-
Mark
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
(
- Contribution to journal › Article
-
Mark
Transcriptomic signatures of tumors undergoing T cell attack
(
- Contribution to journal › Article
-
Mark
B Cells and Tertiary Lymphoid Structures : Friends or Foes in Cancer Immunotherapy?
(
- Contribution to journal › Scientific review
-
Mark
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
(
- Contribution to journal › Article
- 2021
-
Mark
Tumour gene expression signature in primary melanoma predicts long-term outcomes
(
- Contribution to journal › Article
-
Mark
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
(
- Contribution to journal › Article
-
Mark
Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
(
- Contribution to journal › Article
-
Mark
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma
(
- Contribution to journal › Article
-
Mark
BRN2 is a non-canonical melanoma tumor-suppressor
(
- Contribution to journal › Article
-
Mark
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
(
- Contribution to journal › Article
- 2020
-
Mark
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
(
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
(
- Contribution to journal › Article
-
Mark
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
(
- Contribution to journal › Article
-
Mark
CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer
(
- Contribution to journal › Article
-
Mark
The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
(
- Contribution to journal › Article
-
Mark
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
(
- Contribution to journal › Article
-
Mark
Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma
(
- Contribution to journal › Article
-
Mark
Qualitative analysis of tumor-infiltrating lymphocytes across human tumor types reveals a higher proportion of bystander CD8+ T cells in non-melanoma cancers compared to melanoma
(
- Contribution to journal › Article
- 2019
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
(
- Contribution to journal › Article
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
(
- Contribution to journal › Article
-
Mark
Immunoprofiles of colorectal cancer from Lynch syndrome
(
- Contribution to journal › Article
-
Mark
Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma
(
- Contribution to journal › Article
-
Mark
Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma
(
- Contribution to journal › Article
-
Mark
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma
(
- Contribution to journal › Article
-
Mark
Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome
(
- Contribution to journal › Article
-
Mark
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
(
- Contribution to journal › Article
-
Mark
Transcriptomic analysis reveals prognostic molecular signatures of stage I melanoma
(
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
(
- Contribution to journal › Article
- 2018
-
Mark
Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis
(
- Contribution to journal › Article
-
Mark
Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells
(
- Contribution to journal › Article
-
Mark
The genetic evolution of melanoma
2018) p.105-114(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
Acquired immune resistance follows complete tumor regression without loss of target antigens or IFNγ signaling
(
- Contribution to journal › Article
-
Mark
Melanoma genetics and genomics
2017) p.63-93(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
(
- Contribution to journal › Article
-
Mark
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
(
- Contribution to journal › Article
-
Mark
Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series
(
- Contribution to journal › Article
-
Mark
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
(
- Contribution to journal › Article
-
Mark
Rare variant, gene-based association study of hereditary melanoma using whole-exome sequencing
(
- Contribution to journal › Article
- 2016
-
Mark
A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells
(
- Contribution to journal › Article
-
Mark
Prognostic and chemotherapy predictive value of gene-expression phenotypes in primary lung adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
Promoter Methylation of PTEN is a Significant Prognostic Factor in Melanoma Survival.
(
- Contribution to journal › Article
-
Mark
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
(
- Contribution to journal › Article
-
Mark
Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.
(
- Contribution to journal › Article
-
Mark
High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma
(
- Contribution to journal › Letter
-
Mark
Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases
(
- Contribution to journal › Article
-
Mark
Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities
(
- Contribution to journal › Letter
-
Mark
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
(
- Contribution to journal › Article
-
Mark
Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma
(
- Contribution to journal › Article
- 2015
-
Mark
A protein deep sequencing evaluation of metastatic melanoma tissues.
(
- Contribution to journal › Article
-
Mark
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.
(
- Contribution to journal › Article
-
Mark
DNA methylation subgroups in melanoma are associated with proliferative and immunological processes.
(
- Contribution to journal › Article
-
Mark
Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.
(
- Contribution to journal › Article
-
Mark
Molecular characterization of melanoma cases in denmark suspected of genetic predisposition.
(
- Contribution to journal › Article
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.
(
- Contribution to journal › Article
-
Mark
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.
(
- Contribution to journal › Article
-
Mark
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
(
- Contribution to journal › Article
-
Mark
The clinicopathological and gene expression patterns associated with ulceration of primary melanoma
(
- Contribution to journal › Article
-
Mark
CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
(
- Contribution to journal › Article
-
Mark
BAP1 Plays a Survival Role in Cutaneous Melanoma.
(
- Contribution to journal › Article
-
Mark
MITF Modulates Therapeutic Resistance through EGFR Signaling.
(
- Contribution to journal › Article
-
Mark
Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma.
(
- Contribution to journal › Article
-
Mark
A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma
(
- Contribution to journal › Article
- 2014
-
Mark
Analysis of Alpha-Synuclein in Malignant Melanoma - Development of a SRM Quantification Assay.
(
- Contribution to journal › Article
-
Mark
High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.
(
- Contribution to journal › Article
-
Mark
WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells
(
- Contribution to journal › Article
-
Mark
Primary Melanoma Tumors from CDKN2A Mutation Carriers do not Belong to a Distinct Molecular Subclass.
(
- Contribution to journal › Article
-
Mark
Meeting report from the 10th International Congress of the Society for Melanoma Research, Philadelphia, PA, November 2013
(
- Contribution to journal › Article
-
Mark
Inherited variation in the PARP1 gene and survival from melanoma
(
- Contribution to journal › Article
-
Mark
Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
(
- Contribution to journal › Article
-
Mark
A New Look at Drugs Targeting Malignant Melanoma – An Application for Mass Spectrometry Imaging
(
- Contribution to journal › Scientific review
-
Mark
Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome.
(
- Contribution to journal › Article
-
Mark
An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study
(
- Contribution to journal › Article
-
Mark
Feasibility Study on Measuring Selected Proteins in Malignant Melanoma Tissue by SRM Quantification.
(
- Contribution to journal › Article
-
Mark
Molecular and genetic diversity in the metastatic process of melanoma.
(
- Contribution to journal › Article
-
Mark
Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
(
- Contribution to journal › Article
-
Mark
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study
(
- Contribution to journal › Letter
-
Mark
Investigation of a putative melanoma susceptibility locus at chromosome 3q29.
(
- Contribution to journal › Article
- 2013
-
Mark
Mutual Exclusivity Analysis of Genetic and Epigenetic Drivers in Melanoma Identifies a Link Between p14(ARF) and RAR beta Signaling
(
- Contribution to journal › Article
-
Mark
A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers
(
- Contribution to journal › Article
-
Mark
High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer
(
- Contribution to journal › Article
-
Mark
Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability
(
- Contribution to journal › Article
-
Mark
Monitoring of technical variation in quantitative high-throughput datasets.
(
- Contribution to journal › Article
-
Mark
Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer
(
- Contribution to journal › Article
-
Mark
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
(
- Contribution to journal › Article
-
Mark
Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma
(
- Contribution to journal › Article
-
Mark
Vemurafenib Synergizes with Nutlin-3 to Deplete Survivin and Suppresses Melanoma Viability and Tumor Growth
(
- Contribution to journal › Article
-
Mark
Nonfamilial breast cancer subtypes.
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Relation between smoking history and gene expression profiles in lung adenocarcinomas
(
- Contribution to journal › Article
-
Mark
Mutational Processes Molding the Genomes of 21 Breast Cancers
(
- Contribution to journal › Article
-
Mark
Molecular profiling reveals low- and high-grade forms of primary melanoma
(
- Contribution to journal › Article
-
Mark
The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
(
- Contribution to journal › Article
-
Mark
Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
(
- Contribution to journal › Article
- 2011
-
Mark
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
(
- Contribution to journal › Article
-
Mark
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies three new melanoma susceptibility loci
(
- Contribution to journal › Article